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tion critically depend on the health of the ocular surface.
The extraordinary complexity of the ocular surface is main-
tained by intricate homeostasis; destabilization of this equi-
librium may result in devastating consequences. Eyelid
disorders can instigate a deleterious cascade of events, effac-
ing the integrity and functions of the ocular surface epithelia.
In many disease processes (e.g., Stevens-Johnson syndrome,
cicatricial pemphigoid, collagen vascular diseases, burns, or
even chronic blepharitis), the fundamental pathophysiology
produces dysfunctional tear film, anomalous ocular surface
epithelia, and disfigured lids. Disruption of the tear film pro-
gresses to keratoconjunctivitis sicca. Potentially devastating
consequences, such as corneal scarring, infection and blind-
ness, may ensue. Similarly, a healthy ocular surface is an
important prognostic factor for surgical outcome. Accord-
ingly, in this special edition on dry eye and ocular surface dis-
ease (OSD), we endeavor to provide the anterior segment
surgeons with information to manage OSD and ensure opti-
mal eyesight, surgical outcome, and patient satisfaction.
Current literature indicates that the outcome of cataract
surgeries, especially premium IOL implantation, is governed
by OSD. Preexisting OSD is associated with suboptimal visual
outcomes and higher risks of postoperative complications. In
this issue, Movahedan and colleagues1 reviewed the salient
observation between OSD and cataract surgeries. The
authors presented strategies to diagnose and manage these
conditions pre- and post-operatively to ensure optimal out-
come. Amniotic membrane is a versatile tool for ocular sur-
face reconstruction. Katzman and Jeng2 discussed different
management modalities for persistent epithelial defects.
Nguyen et al.3 investigated the role of amniotic membrane
as an adjuvant therapy in high-risk penetrating keratoplasty.
The authors aimed to leverage the anti-inflammatory proper-
ties of amniotic membrane to rehabilitate the ocular surface
and reduce graft rejection; however, no correlation was
determined in this retrospective series.
In severe ocular surface disorders, the loss of limbal epi-
thelial stem cells, or limbal stem cell deficiency (LSCD), has
many deleterious complications, e.g. LSCD is a leading cause
of corneal blindness. The diminished regenerative capacity
seen in LSCD is characterized by persistent epithelial defects,
erosion and ulceration, conjunctivalization and neovasculari-
zation, and chronic inflammation. Lin and Yiu4 provided an
excellent review diagnostic approaches and treatment for
dry eye disease. Tu5 performed a comprehensive review oftoxicity of current ophthalmic eye drops. He and Yiu6
reviewed various stem cell based approaches for treating
LSCD as well as discussing future direction and challenges.
A recent innovation, the prosthetic replacement of the
ocular surface ecosystem (PROSE) scleral lens has been
instrumental in restoring vision and improving patient satis-
faction for a wide range of OSD, e.g. severe dry eye, graft
versus host disease, exposure keratopathy, limbal stem cell
deficiency, as well as corneal ectasia. In this issue, Chiu et al.7
presented that PROSE can improve vision in patients with
Salzmann’s nodular degeneration.
OSD is a challenging adversity for the ophthalmologists.
Successful outcome and patient satisfaction require thorough
evaluation utilizing appropriate clinical tools and comprehen-
sive medical management. Surgical patients necessitate
attentive pre- and post-operative management. Evolution in
the field will continue to arm the surgeons with tools to man-
age this chronic devastating condition.
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